Effect of thymoquinone on transient receptor potential melastatin (TRPM) channels in rats with liver ischemia reperfusion model in rats

Document Type : Original Article

Authors

1 Department of Physiology, School of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey

2 Department of Physiology, School of Medicine, Atlas University, Istanbul, Turkey

3 Department of Physiology, Institute of Health Sciences, Istanbul University Cerrahpasa, Istanbul, Turkey

4 Department of Physiology, School of Medicine, Halic University, Istanbul, Turkey

5 Department of Pathology, School of Medicine, Inonu University, Malatya, Turkey

6 Department of Biochemistry, School of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey

7 Department of Medical Biology, Private Sevgi Hospital, Osmaniye, Turkey

Abstract

Objective(s): We aimed to investigate the levels of transient receptor potential melastatin (TRPM) gene expression, and the antioxidant and histopathologic effect of thymoquinone (Tmq) in the hepatic I/R rat model.
Materials and Methods: Fifty Wistar rats were divided into 5 groups. Group 1: Control; Group 2: Sham; Group 3: Hepatic I/R (45 min/45 min); Group 4: Tmq (50 mg/kg); Group 5: Tmq+I/R (ten days before I/R at the dose of 50 mg/kg of Tmq). The hepatic I/R (45min/45min) model was performed at the portal vein and the hepatic artery with atraumatic vascular clamp in the ischemia groups. The liver tissues and blood samples that were taken at the end of the study were evaluated for histopathologic and biochemical analysis. Besides TRPM gene expression levels were determined in liver tissues. It was seen that cellular swelling, congestion, PNL, and apoptosis parameters statistically decreased in Tmq and Tmq+I/R groups in comparison with the I/R group in histopathological evaluation.
Results: It was observed that biochemical parameters, AST, ALT, GGT, LDH, creatinine, and urea levels significantly increased in the I/R group as compared with, sham, Tmq, and Tmq+I/R groups. It was found that TRPM2,6,7,8 gene expression decreased significantly in Tmq+I/R groups as compared to the I/R group. 
Conclusion: We showed that thymoquinone can inhibit the entry of Ca+2 into the cell by decreasing TRPM2,6,7,8 gene expression. Based on our findings, we think that Tmq application in the treatment of liver diseases due to I/R damage may be important in terms of both ischemia and apoptosis and can also be used in the treatment of liver-related diseases.

Keywords

Main Subjects


1. Mohamadian M, Parsamanesh N, Chiti H, Sathyapalan T, Sahebkar A. Protective effects of curcumin on ischemia/reperfusion injury. Phytother Res  2022; 36:4299-4324.
2. Aamani N, Bagheri A, Masoumi Qajari N, Malekzadeh Shafaroudi M, Khonakdar-Tarsi A. JNK and p38 gene and protein expression during liver ischemia-reperfusion in a rat model treated with silibinin. Iran J Basic Med Sci  2022; 25:1373-1381.
3. Oskouei Z, Akaberi M, Hosseinzadeh H. A glance at black cumin (Nigella sativa) and its active constituent, thymoquinone, in ischemia: A review. Iran J Basic Med Sci  2018; 21:1200-1209.
4. Tania M, Asad A, Li T, Islam MS, Islam SB, Hossen MM, et al. Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics. Iran J Basic Med Sci  2021; 24:1014-1022.
5. Gulmez MI, Okuyucu S, Dokuyucu R, Gokce H. The effect of caffeic acid phenethyl ester and thymoquinone on otitis media with effusion in rats. Int J Pediatr Otorhinolaryngol 2017;96:94-99.
6. Demirel H, Arli C, Ozgur T, Inci M, Dokuyucu R. The role of topical thymoquinone in the treatment of acute otitis externa; an experimental study in rats. J Int Adv Otol  2018; 14:285-259.
7. Verma R, Sartaj A, Qizilbash FF, Ghoneim MM, Alshehri S, Imam SS, et al. An overview of the neuropharmacological potential of thymoquinone and its targeted delivery prospects for CNS disorder. Curr Drug Metab 2022; 23:447-459.
8. Islam MN, Hossain KS, Sarker PP, Ferdous J, Hannan MA, Rahman MM, et al. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytother Res 2021; 35:1329-1344.
9. Farag MM, Khalifa AA, Elhadidy WF, Rashad RM. Hepatorenal protection in renal ischemia/reperfusion by celecoxib and pentoxifylline. J Surg Res 2016; 204:183-191.
10. Atabay H, Demir T, Dokuyucu R, Yumrutas O, Oztuzcu S, Ceribasi A, et al. The effects of lung ischaemia/reperfusion on TRPM gene expression. West Indian Med J  2021; 69:326-331.
11. Huang Q, Wang X, Lin X, Zhang J, You X, Shao A. The role of transient receptor potential channels in blood-brain barrier dysfunction after ischemic stroke. Biomed Pharmacother 2020; 131:110647-110653.
12. Cornillot M, Giacco V, Hamilton NB. The role of TRP channels in white matter function and ischaemia. Neurosci Lett 2019; 690:202-209.
13. Pei Z, Hu J, Bai Q, Liu B, Cheng D, Liu H, et al. Thymoquinone protects against cardiac damage from doxorubicin-induced heart failure in Sprague-Dawley rats. RSC Adv 2018; 8:14633-14639.
14. Khbouz B, Gu S, Pinto Coelho T, Lallemand F, Jouret F. Radiotherapy advances in renal disease-focus on renal ischemic preconditioning. Bioengineering (Basel) 2023; 10:1-10.
15. Zhang K, Xu X, Hu L. Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway. Ann Transl Med  2022; 10:1-14.
16. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014; 47:326-332.
17. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37:277-285.
18. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103-1111.
19. Cakirca G, Manav V, Celik H, Saracoglu G, Yetkin EN. Effects of anxiety and depression symptoms on oxidative stress in patients with alopecia areata. Postepy Dermatol Alergol 2020; 37:412-416.
20. Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. Caffeic acid phenethyl ester: A review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions. Crit Rev Food Sci Nutr 2016; 56:2183-2190.
21. Wu Z, Ma Y, Zhao L, Cai S, Cheng G. Acute and subchronic toxicities of the ethanol and hot-water extracts from Chinese sumac (Rhus chinensis Mill.) fruits by oral administration in rats. Food Chem Toxicol 2018; 119:14-23.
22. Yildiz F, Coban S, Terzi A, Ates M, Aksoy N, Cakir H, et al. Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J Gastroenterol  2008; 14:5204-5209.
23. Huseyin S, Guclu O, Yuksel V, Erkul GSA, Can N, Turan FN, et al. Avoiding liver injury with papaverine and ascorbic acid due to infrarenal cross-clamping: An experimental study. Braz J Cardiovasc Surg 2017; 32:197-201.
24. Abuzinadah MF, Ahmad A. Pharmacological studies on the efficacy of a thymoquinone-containing novel polyherbal formulation against cisplatin-induced hepatorenal toxicity in rats. J Food Biochem 2020; 44:e13131.
25. Abd El-Ghany RM, Sharaf NM, Kassem LA, Mahran LG, Heikal OA. Thymoquinone triggers anti-apoptotic signaling targeting death ligand and apoptotic regulators in a model of hepatic ischemia reperfusion injury. Drug Discov Ther 2009; 3:296-306.
26. El-Abhar HS, Abdallah DM, Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol 2003; 84:251-258.
27. Bayramoglu G, Bayramoglu A, Engur S, Senturk H, Ozturk N, Colak S. The hepatoprotective effects of Hypericum perforatum L. on hepatic ischemia/reperfusion injury in rats. Cytotechnology  2014; 66:443-448.
28. Kim SK, Jee D, Kim JY, Choi JH. Effects of propofol on early phase of warm hepatic ischemia/reperfusion injury. Hepatogastroenterology 2007; 54:2333-2336.
29. Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, et al. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther 2001; 298:894-899.
30. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RC, Mathie RT. Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterol  2002; 2:1-6.
31. Yildirim S, Tok H, Koksal H, Erdem L, Baykan A. Allopurinol plus pentoxifilline in hepatic ischaemia/reperfusion injury. Asian J Surg 2002; 25:149-153.
32. Bilecik T, Karateke F, Elkan H, Gokce H. The effects of TRPM2, TRPM6, TRPM7 and TRPM8 gene expression in hepatic ischemia reperfusion injury. Eur Rev Med Pharmacol Sci 2019; 23:3088-3095.
33. Anderson KJ, Cormier RT, Scott PM. Role of ion channels in gastrointestinal cancer. World J Gastroenterol  2019; 25:5732-5772.